Global Next Generation Cancer Diagnostics Market to Grow 32.3% by 2022 - Anticipated to Reach $20.9 Billion - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Next Generation Cancer Diagnostics Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023" report to their offering.

The global next generation cancer diagnostics market is projected to grow CAGR 32.3% during 2016-2022. The market is anticipated to reach $20.9billion by 2022.

Increasing prevalence of cancer, increasing funding for research & development, favourable support from government and regulatory bodies are the driving factors of next generation cancer diagnostics market in North America and Europe. Asia Pacific is the fastest growing next generation cancer diagnostics market for the forecasted period. Asia Pacific market is growing at CAGR 12%.

According to National Institute of Health's report; An Aging World: 2015, the world's geriatric population (aged 65 and over) to be 8.5% in 2015. According to the report around 17% of the total world population by 2050 will be aged 65 years and above. Age is the major factor for developing cancer. Around 60% of population aged 65 years and above have cancer. Along with cancer, an individual also suffers from heart conditions, lung disease, and kidney disease. Liver cancer, Kidney cancer, and Stomach cancer are some of the common cancers occurring in geriatric population.

Countries like Japan, Germany, Greece, and Italy, with an average geriatric population of over 25% will be a lucrative market for next generation cancer diagnostics. Stringent regulatory guidelines, rising competition among market players, dearth of experienced and skills personnel, high investment capital and varying regulatory compliance rules of different countries are the challenges deliberated in the market research report.

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies
  • Ge Healthcare
  • Genomic Health Inc
  • Hologic Inc
  • Illumina Inc
  • Johnson & Johnson
  • Myriad Genetics Inc
  • Novartis Ag
  • Opko Health Inc
  • Perking Elmer Inc
  • Philips Electronics Nv
  • Qiagen
  • Roche Holding
  • Thermo Fisher Scientific Inc

Key Topics Covered:

1. Introduction

2. Market Overview

3. Market Determinants

4. Market Segmentation

5. Competitive Landscape

6. Global Next Generation Cancer Diagnostics Market by Region (Revenue Analysis) 2014-2022 ($ Million)

7. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/jxc2wf/global_next

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Diagnostics